ciprofloxacin has been researched along with curcumin in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (7.14) | 29.6817 |
2010's | 8 (57.14) | 24.3611 |
2020's | 5 (35.71) | 2.80 |
Authors | Studies |
---|---|
Balaji, NV; Hari Babu, B; Murali Krishna Kumar, M; Purna Nagasree, K; Subbaraju, GV | 1 |
Bi, F; Hu, C; Liu, J; Ma, R; Ma, S; Semple, SJ; Venter, H; Zhang, F | 1 |
Capito, JE; El-Manawaty, MA; George, RF; Girgis, AS; Panda, SS; Salman, A; Samir, A; Thomas, SJ | 1 |
Altunatmaz, K; Aydin, S; Gülçubuk, A; Gürel, A; Gürler, N; Güzel, O; Oksüz, L; Sönmez, K; Uzun, H | 1 |
Ajitkumar, P; Chakravortty, D; Kumar, R; Marathe, SA; Nagaraja, V | 1 |
Joung, DK; Kang, OH; Kim, SB; Kim, YC; Kim, YS; Kweon, KT; Kwon, DY; Lee, DS; Mun, SH; Seo, YS; Shin, DW | 1 |
Hadinoto, K; Yang, Y | 1 |
Ali, SA; Teow, SY | 1 |
Bahari, S; Haghi, F; Mirshahabi, H; Roudashti, S; Soltani, A; Zeighami, H | 1 |
Rahbar Takrami, S; Ranji, N; Sadeghizadeh, M | 1 |
de Souza Carvalho-Wodarz, C; Lababidi, N; Lehr, CM; Montefusco-Pereira, CV; Schneider, M | 1 |
Asgary, S; Heydari, P; Parham, S; Zargar Kharazi, A | 1 |
Argentini, C; Filippini, R; Giusti, P; Moro, S; Piovan, A; Zusso, M | 1 |
Abbas, M; Hussain, RA; Idrees, K; Jaffer, M; Rasool, G; Shaheen, S; Tabassum, MW | 1 |
14 other study(ies) available for ciprofloxacin and curcumin
Article | Year |
---|---|
Synthesis, screening and docking analysis of hispolon analogs as potential antitubercular agents.
Topics: Antitubercular Agents; Catechols; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2017 |
Novel 5-methyl-2-phenylphenanthridium derivatives as FtsZ-targeting antibacterial agents from structural simplification of natural product sanguinarine.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Benzophenanthridines; Binding Sites; Biological Products; Cytoskeletal Proteins; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Isoquinolines; Microbial Sensitivity Tests; Molecular Dynamics Simulation; Phenanthridines; Protein Structure, Tertiary; Structure-Activity Relationship | 2018 |
Synthesis, pharmacological profile and 2D-QSAR studies of curcumin-amino acid conjugates as potential drug candidates.
Topics: Amino Acids; Analgesics; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Candida albicans; Carrageenan; Cell Proliferation; Curcumin; Dose-Response Relationship, Drug; Edema; Mice; Microbial Sensitivity Tests; Molecular Structure; Pain; Pseudomonas aeruginosa; Quantitative Structure-Activity Relationship; Rats; Salmonella typhi; Spleen; Staphylococcus aureus; Streptococcus pyogenes; Ulcer | 2020 |
Pathologic alterations detected in acute pancreatitis induced by sodium taurocholate in rats and therapeutic effects of curcumin, ciprofloxacin and metronidazole combination.
Topics: Animals; Anti-Infective Agents; Antioxidants; Bacterial Translocation; Ciprofloxacin; Curcumin; Disease Models, Animal; Drug Therapy, Combination; Enzyme Inhibitors; Male; Metronidazole; Pancreatitis, Acute Necrotizing; Rats; Rats, Wistar; Taurocholic Acid; Treatment Outcome | 2005 |
Curcumin reduces the antimicrobial activity of ciprofloxacin against Salmonella typhimurium and Salmonella typhi.
Topics: Animals; Anti-Infective Agents; Antioxidants; Ciprofloxacin; Curcumin; Drug Interactions; Humans; Macrophages; Mice; Mice, Inbred BALB C; Salmonella Infections; Salmonella typhi; Salmonella typhimurium; U937 Cells | 2013 |
Synergistic antibacterial effect of curcumin against methicillin-resistant Staphylococcus aureus.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Curcuma; Curcumin; Drug Synergism; Humans; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Norfloxacin; Oxacillin; Plant Extracts; Rhizome; Time Factors | 2013 |
A highly sustainable and versatile granulation method of nanodrugs via their electrostatic adsorption onto chitosan microparticles as the granulation substrates.
Topics: Adsorption; Chemistry, Pharmaceutical; Chitosan; Ciprofloxacin; Curcumin; Nanoparticles; Static Electricity | 2013 |
Synergistic antibacterial activity of Curcumin with antibiotics against Staphylococcus aureus.
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Curcumin; Disk Diffusion Antimicrobial Tests; Dose-Response Relationship, Drug; Drug Synergism; Gentamicins; Phytotherapy; Plant Extracts; Plants, Medicinal; Staphylococcus aureus; Time Factors | 2015 |
Synergistic activity of sub-inhibitory concentrations of curcumin with ceftazidime and ciprofloxacin against Pseudomonas aeruginosa quorum sensing related genes and virulence traits.
Topics: Anti-Bacterial Agents; Biofilms; Ceftazidime; Ciprofloxacin; Curcumin; Drug Synergism; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Microbial Sensitivity Tests; Microbial Viability; Pseudomonas aeruginosa; Quorum Sensing; Virulence; Virulence Factors | 2017 |
Antibacterial effects of curcumin encapsulated in nanoparticles on clinical isolates of Pseudomonas aeruginosa through downregulation of efflux pumps.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; Ciprofloxacin; Curcumin; Down-Regulation; Drug Resistance, Multiple; Drug Resistance, Multiple, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Nanoparticles; Pseudomonas aeruginosa | 2019 |
Spray-dried multidrug particles for pulmonary co-delivery of antibiotics with N-acetylcysteine and curcumin-loaded PLGA-nanoparticles.
Topics: Acetylcysteine; Administration, Inhalation; Anti-Bacterial Agents; Anti-Inflammatory Agents; Azithromycin; Ciprofloxacin; Curcumin; Cytokines; Drug Carriers; Drug Combinations; Drug Compounding; Expectorants; Freeze Drying; Humans; Inflammation Mediators; Macrophages; Microbial Viability; Mucus; Nanoparticles; Permeability; Polylactic Acid-Polyglycolic Acid Copolymer; Pseudomonas aeruginosa; Pseudomonas Infections; THP-1 Cells; Tobramycin | 2020 |
Comparing the wound healing effect of a controlled release wound dressing containing curcumin/ciprofloxacin and simvastatin/ciprofloxacin in a rat model: A preclinical study.
Topics: Animals; Anti-Bacterial Agents; Bandages; Ciprofloxacin; Curcumin; Delayed-Action Preparations; Rats; Simvastatin; Wound Healing | 2022 |
The Effect of C-Phycocyanin on Microglia Activation Is Mediated by Toll-like Receptor 4.
Topics: Animals; Cell Proliferation; Cell Survival; Cells, Cultured; Ciprofloxacin; Curcumin; Immunomodulating Agents; Interleukin-1beta; Microglia; Phycocyanin; Primary Cell Culture; Rats; Spirulina; Sulfonamides; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2022 |
Light microscopy and scanning electron microscopy: A helping tool to identify the adultrant of dye from Curcuma longa L rhizome, and its ecofriendly applications on pharmaceutical products.
Topics: Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Curcuma; Microscopy, Electron, Scanning; Plant Extracts; Rhizome | 2022 |